PanTher Therapeutics, Inc. — Form D
PanTher Therapeutics, Inc. of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-03. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-03
- Form: D
- Accession: 0001644045-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Investors: 26
- Date of first sale: 2025-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542862
Issuer
- Name: PanTher Therapeutics, Inc.
- CIK: 0001644045
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 7000 Bee Caves Road, Austin, TX, 78746
- Phone: 8574131698
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Laura Indolfi | Director | Austin, TX |
| D Mackey | Director | Austin, TX |
| Maria Palasis | Director | Austin, TX |
| Daniel Wildman | Director | Austin, TX |
| Darshana Zaveri | Director | BEDFORD, MA |
| Laura Indolfi | Executive Officer | Austin, TX |
| John Edwards | Director | Atlanta, GA |
| Manish Bhandari | Director | Austin, TX |
| David Ting | Director | Chicago, IL |
| ELAZER EDELMAN | Director | DRAPER, UT |
Other filings by this issuer (9)
More